NRHS contributor

Carolyne Oketch

Kisumu, Kenya

Carolyne Oketch contributes to research, programmes and public health communication at the Nyanza Reproductive Health Society.

3published articles

From the author

Articles and updates

Research, stories and organisational updates published by Carolyne Oketch.

news

The EXPrESSIVE-11 Study: Advancing HIV Prevention Through Monthly Oral PrEP

The Nyanza Reproductive Health Society (NRHS) is participating in the EXPrESSIVE-11 Study, an international Phase 3 clinical trial evaluating a new once-monthly oral medication for HIV prevention known as MK-8527. The study seeks to determine the efficacy and safety of MK-8527 as a form of HIV-1 pre-exposure prophylaxis (PrEP) among populations at increased likelihood of HIV exposure. The investigational medication is being compared to the currently approved daily oral PrEP regimen consisting o

NRHSResearch • Evidence • Impact

research

FAST Research Study - Assessments of the efficacy, the Onset-of-Action and the Safety of Tot'héma® in adults with moderate Iron deficiency anemia

At Nyanza Reproductive Health Society (NRHS), we’re committed to improving the health and well-being of communities in Kenya. We’re currently involved in an exciting clinical trial, FAST, which evaluates the effectiveness and safety of Tot'héma®, an oral solution used to treat moderate iron deficiency anemia (IDA) in adults. This trial, now at the data analysis stage, has the potential to change how we approach anemia treatment in the region and beyond. What is Iron Deficiency Anemia (IDA)? Ir

NRHSResearch • Evidence • Impact

research

The Mambo Matatu Study: A Game Changer for STI Prevention in Kenya

Imagine this: You're young, navigating relationships, and trying to stay safe. But in Kenya, where sexually transmitted infections (STIs) remain a serious concern—especially among men who have sex with men (MSM)—finding effective protection isn't always straightforward. That's where the Mambo Matatu Study comes in. What’s the Big Deal? Right now, MSM in Kenya face high rates of STIs, yet most healthcare centers rely on syndromic treatment—meaning you only get treated after symptoms appear. B